EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Blood pressure management in secondary prevention after myocardial infarction

Massimo Volpe iD, Giovanna Gallo iD, Tomasz J Guzik, Bryan Williams iD, Franz H Messerli

Cardiovascular Research · 2025

DOI: 10.1093/cvr/cvaf145 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Research, 2025. Verfasst von Massimo Volpe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Molecular Medicine, Sapienza University of Rome, Via di Grottarossa 1035-1035, 00189 Rome, Italy. Hauptthemen laut MEDLINE: Secondary Prevention, Myocardial Infarction, Blood Pressure, Antihypertensive Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The management of blood pressure (BP) in secondary prevention after acute myocardial infarction (AMI) remains a matter of debate. Since no dedicated trials have specifically addressed BP control in patients recovering from an acute coronary syndrome, there are no evidence-based, prospective data to define precise BP targets in this population. Moreover, major international guidelines devote surprisingly little attention to BP management in the post-AMI setting, despite its recognized importance in reducing recurrent cardiovascular events. On one hand, BP-lowering may improve cardiac function by reducing afterload and myocardial oxygen consumption and by facilitating favourable ventricular remodelling. On the other hand, the concept of a J-shaped association—whereby excessive lowering of diastolic blood pressure may paradoxically increase cardiovascular risk, particularly in the early post-AMI period—remains a matter of ongoing uncertainty. Despite decades of investigation, this issue has not been definitively resolved and continues to raise debate within both the scientific community and among clinicians. In this review, we examine the current evidence supporting BP control in the context of secondary prevention following AMI, with an updated focus on the ongoing debate surrounding the potential implications of the J-shaped phenomenon.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Secondary PreventionMyocardial InfarctionBlood PressureAntihypertensive AgentsHypertensionHumansRisk FactorsTreatment OutcomeRisk AssessmentRecurrence

Stichwörter der Autor:innen

Acute coronary syndromesBlood pressure managementCoronary artery diseaseJ-curve phenomenonSecondary prevention

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Department of Clinical and Molecular Medicine, Sapienza University of Rome, Via di Grottarossa 1035-1035, 00189 Rome, Italy.
  • IRCCS S. Raffaele, Via della Pisana 235, 00163 Rome, Italy.
  • Cardiology Unit, Sant'Andrea University Hospital, Rome, Italy.
  • Centre for Cardiovascular Sciences, BHF Cardiovascular Research Centre, University of Edinburgh, Edinburgh, UK.
  • Department of Medicine, Jagiellonian University, Krakow, Poland.
  • UCL Hospitals Biomedical Research Centre, University College London (UCL), Institute of Cardiovascular Science, National Institute for Health Research, London, UK.

ORCID-Profile: Massimo Volpe, Giovanna Gallo, Bryan Williams

Förderung

  • Italian Ministry of Health

Zitieren

APA

Volpe, M., Gallo, G., Guzik, T. J., Williams, B., & Messerli, F. H. (2025). Blood pressure management in secondary prevention after myocardial infarction. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf145

Vancouver

Volpe M, Gallo G, Guzik TJ, Williams B, Messerli FH. Blood pressure management in secondary prevention after myocardial infarction. Cardiovascular Research. 2025. doi:10.1093/cvr/cvaf145

BibTeX
@article{Volpe2025,
  author = {Volpe, Massimo and Gallo, Giovanna and Guzik, Tomasz J and Williams, Bryan and Messerli, Franz H},
  title = {Blood pressure management in secondary prevention after myocardial infarction},
  journal = {Cardiovascular Research},
  year = {2025},
  doi = {10.1093/cvr/cvaf145}
}
Kostenlos starten →